Skip Navigation

A Phase II Study of M1774 in Refractory SPOP-Mutant Prostate Cancer

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05828082

Study #:
STUDY00150798

Start Date:
Jan 23, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05828082

View Complete Trial Details & Eligibility at ClinicalTrials.gov